secwatch.observer — SEC 8-K summary
======================================

Issuer:     MYRIAD GENETICS INC (MYGN)
CIK:        0000899923
Form:       8-K
Filed at:   2025-10-07T23:59:59+00:00
Accession:  0000899923-25-000096
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Myriad Genetics finalizes separation agreement with former CFO Scott Leffler; $1.24M severance plus equity acceleration
--------------------------------------------------------------------------------

- Scott J. Leffler's separation effective Sep 2, 2025; lump-sum severance payment of $1,239,384.
- Unvested time-based equity awards scheduled to vest within 2 years accelerated; performance-based awards remain outstanding.
- COBRA medical premiums paid by company for up to one year after separation date.
- Leffler reaffirms non-compete, non-solicitation, and non-disparagement obligations.
- Company provides neutral references; no admission of liability.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/899923/000089992325000096/0000899923-25-000096-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/899923/000089992325000096/mygn-20251001.htm
  HTML page:      https://secwatch.observer/filing/0000899923-25-000096

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer